Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Work In Process: 2024

Historic Work In Process for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Dec 2024 value amounting to $330,000.

  • Syndax Pharmaceuticals' Work In Process was N/A to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $330,000 for FY2024, which is N/A change from last year.
  • As of FY2024, Syndax Pharmaceuticals' Work In Process stood at $330,000.
  • Syndax Pharmaceuticals' Work In Process' 5-year high stood at $330,000 during FY2024, with a 5-year trough of $330,000 in FY2024.
  • Moreover, its 1-year median value for Work In Process was $330,000 (2024), whereas its average is $330,000.